Mature T cell reactivity altered by peptide agonist that induces positive selection (original) (raw)

Abstract

Recent studies have investigated how defined peptides influence T cell development. Using a T cell receptor-transgenic beta2-microglobulin- deficient model, we have examined T cell maturation in fetal thymic organ cultures in the presence of various peptides containing single- alanine substitutions of the strong peptide agonist, p33. Cocultivation with the peptide A4Y, which contains an altered T cell contact residue, resulted in efficient positive selection. Several in vitro assays demonstrated that A4Y was a moderate agonist relative to p33. Although A4Y promoted positive selection over a wide concentration range, high doses of this peptide could not induce clonal deletion. Thymocytes maturing in the presence of A4Y were no longer able to respond to A4Y, but could proliferate against p33. These studies demonstrate that (a) peptides that induce efficient positive selection at high concentrations are not exclusively antagonists; (b) some agonists do not promote clonal deletion; (c) positive selection requires a unique T cell receptor-peptide-major histocompatibility complex interaction; and (d) interactions with selecting peptides during T cell ontogeny may define the functional reactivity of mature T cells.

Full Text

The Full Text of this article is available as a PDF (1.3 MB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Allen H., Fraser J., Flyer D., Calvin S., Flavell R. Beta 2-microglobulin is not required for cell surface expression of the murine class I histocompatibility antigen H-2Db or of a truncated H-2Db. Proc Natl Acad Sci U S A. 1986 Oct;83(19):7447–7451. doi: 10.1073/pnas.83.19.7447. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Ashton-Rickardt P. G., Bandeira A., Delaney J. R., Van Kaer L., Pircher H. P., Zinkernagel R. M., Tonegawa S. Evidence for a differential avidity model of T cell selection in the thymus. Cell. 1994 Feb 25;76(4):651–663. doi: 10.1016/0092-8674(94)90505-3. [DOI] [PubMed] [Google Scholar]
  3. Ashton-Rickardt P. G., Tonegawa S. A differential-avidity model for T-cell selection. Immunol Today. 1994 Aug;15(8):362–366. doi: 10.1016/0167-5699(94)90174-0. [DOI] [PubMed] [Google Scholar]
  4. Ashton-Rickardt P. G., Van Kaer L., Schumacher T. N., Ploegh H. L., Tonegawa S. Peptide contributes to the specificity of positive selection of CD8+ T cells in the thymus. Cell. 1993 Jun 4;73(5):1041–1049. doi: 10.1016/0092-8674(93)90281-t. [DOI] [PubMed] [Google Scholar]
  5. Berg L. J., Frank G. D., Davis M. M. The effects of MHC gene dosage and allelic variation on T cell receptor selection. Cell. 1990 Mar 23;60(6):1043–1053. doi: 10.1016/0092-8674(90)90352-f. [DOI] [PubMed] [Google Scholar]
  6. Blackman M. A., Burgert H. G., Gerhard-Burgert H., Woodland D. L., Palmer E., Kappler J. W., Marrack P. A role for clonal inactivation in T cell tolerance to Mls-1a. Nature. 1990 Jun 7;345(6275):540–542. doi: 10.1038/345540a0. [DOI] [PubMed] [Google Scholar]
  7. Bonomo A., Matzinger P. Thymus epithelium induces tissue-specific tolerance. J Exp Med. 1993 Apr 1;177(4):1153–1164. doi: 10.1084/jem.177.4.1153. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Boyd R. L., Tucek C. L., Godfrey D. I., Izon D. J., Wilson T. J., Davidson N. J., Bean A. G., Ladyman H. M., Ritter M. A., Hugo P. The thymic microenvironment. Immunol Today. 1993 Sep;14(9):445–459. doi: 10.1016/0167-5699(93)90248-J. [DOI] [PubMed] [Google Scholar]
  9. Cobbold S. P., Jayasuriya A., Nash A., Prospero T. D., Waldmann H. Therapy with monoclonal antibodies by elimination of T-cell subsets in vivo. Nature. 1984 Dec 6;312(5994):548–551. doi: 10.1038/312548a0. [DOI] [PubMed] [Google Scholar]
  10. Crispe I. N., Bevan M. J. Expression and functional significance of the J11d marker on mouse thymocytes. J Immunol. 1987 Apr 1;138(7):2013–2018. [PubMed] [Google Scholar]
  11. De Magistris M. T., Alexander J., Coggeshall M., Altman A., Gaeta F. C., Grey H. M., Sette A. Antigen analog-major histocompatibility complexes act as antagonists of the T cell receptor. Cell. 1992 Feb 21;68(4):625–634. doi: 10.1016/0092-8674(92)90139-4. [DOI] [PubMed] [Google Scholar]
  12. Evavold B. D., Allen P. M. Separation of IL-4 production from Th cell proliferation by an altered T cell receptor ligand. Science. 1991 May 31;252(5010):1308–1310. doi: 10.1126/science.1833816. [DOI] [PubMed] [Google Scholar]
  13. Evavold B. D., Sloan-Lancaster J., Allen P. M. Tickling the TCR: selective T-cell functions stimulated by altered peptide ligands. Immunol Today. 1993 Dec;14(12):602–609. doi: 10.1016/0167-5699(93)90200-5. [DOI] [PubMed] [Google Scholar]
  14. Evavold B. D., Sloan-Lancaster J., Wilson K. J., Rothbard J. B., Allen P. M. Specific T cell recognition of minimally homologous peptides: evidence for multiple endogenous ligands. Immunity. 1995 Jun;2(6):655–663. doi: 10.1016/1074-7613(95)90010-1. [DOI] [PubMed] [Google Scholar]
  15. Grossman Z. Cellular tolerance as a dynamic state of the adaptable lymphocyte. Immunol Rev. 1993 Jun;133:45–73. doi: 10.1111/j.1600-065x.1993.tb01509.x. [DOI] [PubMed] [Google Scholar]
  16. Grossman Z., Paul W. E. Adaptive cellular interactions in the immune system: the tunable activation threshold and the significance of subthreshold responses. Proc Natl Acad Sci U S A. 1992 Nov 1;89(21):10365–10369. doi: 10.1073/pnas.89.21.10365. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Haskins K., Hannum C., White J., Roehm N., Kubo R., Kappler J., Marrack P. The antigen-specific, major histocompatibility complex-restricted receptor on T cells. VI. An antibody to a receptor allotype. J Exp Med. 1984 Aug 1;160(2):452–471. doi: 10.1084/jem.160.2.452. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Hogquist K. A., Gavin M. A., Bevan M. J. Positive selection of CD8+ T cells induced by major histocompatibility complex binding peptides in fetal thymic organ culture. J Exp Med. 1993 May 1;177(5):1469–1473. doi: 10.1084/jem.177.5.1469. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Hogquist K. A., Jameson S. C., Bevan M. J. Strong agonist ligands for the T cell receptor do not mediate positive selection of functional CD8+ T cells. Immunity. 1995 Jul;3(1):79–86. doi: 10.1016/1074-7613(95)90160-4. [DOI] [PubMed] [Google Scholar]
  20. Hogquist K. A., Jameson S. C., Heath W. R., Howard J. L., Bevan M. J., Carbone F. R. T cell receptor antagonist peptides induce positive selection. Cell. 1994 Jan 14;76(1):17–27. doi: 10.1016/0092-8674(94)90169-4. [DOI] [PubMed] [Google Scholar]
  21. Hugo P., Kappler J. W., Marrack P. C. Positive selection of TcR alpha beta thymocytes: is cortical thymic epithelium an obligatory participant in the presentation of major histocompatibility complex protein? Immunol Rev. 1993 Oct;135:133–155. doi: 10.1111/j.1600-065x.1993.tb00647.x. [DOI] [PubMed] [Google Scholar]
  22. Jameson S. C., Hogquist K. A., Bevan M. J. Positive selection of thymocytes. Annu Rev Immunol. 1995;13:93–126. doi: 10.1146/annurev.iy.13.040195.000521. [DOI] [PubMed] [Google Scholar]
  23. Jameson S. C., Hogquist K. A., Bevan M. J. Specificity and flexibility in thymic selection. Nature. 1994 Jun 30;369(6483):750–752. doi: 10.1038/369750a0. [DOI] [PMC free article] [PubMed] [Google Scholar]
  24. Janeway C. A., Jr Ligands for the T-cell receptor: hard times for avidity models. Immunol Today. 1995 May;16(5):223–225. doi: 10.1016/0167-5699(95)80163-4. [DOI] [PubMed] [Google Scholar]
  25. Janeway C. A., Jr Thymic selection: two pathways to life and two to death. Immunity. 1994 Apr;1(1):3–6. doi: 10.1016/1074-7613(94)90003-5. [DOI] [PubMed] [Google Scholar]
  26. Kappler J. W., Staerz U., White J., Marrack P. C. Self-tolerance eliminates T cells specific for Mls-modified products of the major histocompatibility complex. Nature. 1988 Mar 3;332(6159):35–40. doi: 10.1038/332035a0. [DOI] [PubMed] [Google Scholar]
  27. Kast W. M., Offringa R., Peters P. J., Voordouw A. C., Meloen R. H., van der Eb A. J., Melief C. J. Eradication of adenovirus E1-induced tumors by E1A-specific cytotoxic T lymphocytes. Cell. 1989 Nov 17;59(4):603–614. doi: 10.1016/0092-8674(89)90006-8. [DOI] [PubMed] [Google Scholar]
  28. Kawai K., Ohashi P. S. Immunological function of a defined T-cell population tolerized to low-affinity self antigens. Nature. 1995 Mar 2;374(6517):68–69. doi: 10.1038/374068a0. [DOI] [PubMed] [Google Scholar]
  29. Kisielow P., Blüthmann H., Staerz U. D., Steinmetz M., von Boehmer H. Tolerance in T-cell-receptor transgenic mice involves deletion of nonmature CD4+8+ thymocytes. Nature. 1988 Jun 23;333(6175):742–746. doi: 10.1038/333742a0. [DOI] [PubMed] [Google Scholar]
  30. Koller B. H., Marrack P., Kappler J. W., Smithies O. Normal development of mice deficient in beta 2M, MHC class I proteins, and CD8+ T cells. Science. 1990 Jun 8;248(4960):1227–1230. doi: 10.1126/science.2112266. [DOI] [PubMed] [Google Scholar]
  31. Luescher I. F., Lóez J. A., Malissen B., Cerottini J. C. Interaction of antigenic peptides with MHC class I molecules on living cells studied by photoaffinity labeling. J Immunol. 1992 Feb 15;148(4):1003–1011. [PubMed] [Google Scholar]
  32. MacDonald H. R., Schneider R., Lees R. K., Howe R. C., Acha-Orbea H., Festenstein H., Zinkernagel R. M., Hengartner H. T-cell receptor V beta use predicts reactivity and tolerance to Mlsa-encoded antigens. Nature. 1988 Mar 3;332(6159):40–45. doi: 10.1038/332040a0. [DOI] [PubMed] [Google Scholar]
  33. Madrenas J., Wange R. L., Wang J. L., Isakov N., Samelson L. E., Germain R. N. Zeta phosphorylation without ZAP-70 activation induced by TCR antagonists or partial agonists. Science. 1995 Jan 27;267(5197):515–518. doi: 10.1126/science.7824949. [DOI] [PubMed] [Google Scholar]
  34. Mannie M. D. A unified model for T cell antigen recognition and thymic selection of the T cell repertoire. J Theor Biol. 1991 Jul 21;151(2):169–192. doi: 10.1016/s0022-5193(05)80360-1. [DOI] [PubMed] [Google Scholar]
  35. Martien van Santen H., Woolsey A., Rickardt P. G., Van Kaer L., Baas E. J., Berns A., Tonegawa S., Ploegh H. L. Increase in positive selection of CD8+ T cells in TAP1-mutant mice by human beta 2-microglobulin transgene. J Exp Med. 1995 Feb 1;181(2):787–792. doi: 10.1084/jem.181.2.787. [DOI] [PMC free article] [PubMed] [Google Scholar]
  36. Nanda N. K., Arzoo K. K., Geysen H. M., Sette A., Sercarz E. E. Recognition of multiple peptide cores by a single T cell receptor. J Exp Med. 1995 Aug 1;182(2):531–539. doi: 10.1084/jem.182.2.531. [DOI] [PMC free article] [PubMed] [Google Scholar]
  37. Nossal G. J. Negative selection of lymphocytes. Cell. 1994 Jan 28;76(2):229–239. doi: 10.1016/0092-8674(94)90331-x. [DOI] [PubMed] [Google Scholar]
  38. Ostrov D., Krieger J., Sidney J., Sette A., Concannon P. T cell receptor antagonism mediated by interaction between T cell receptor junctional residues and peptide antigen analogues. J Immunol. 1993 May 15;150(10):4277–4283. [PubMed] [Google Scholar]
  39. Page D. M., Alexander J., Snoke K., Appella E., Sette A., Hedrick S. M., Grey H. M. Negative selection of CD4+ CD8+ thymocytes by T-cell receptor peptide antagonists. Proc Natl Acad Sci U S A. 1994 Apr 26;91(9):4057–4061. doi: 10.1073/pnas.91.9.4057. [DOI] [PMC free article] [PubMed] [Google Scholar]
  40. Pircher H., Bürki K., Lang R., Hengartner H., Zinkernagel R. M. Tolerance induction in double specific T-cell receptor transgenic mice varies with antigen. Nature. 1989 Nov 30;342(6249):559–561. doi: 10.1038/342559a0. [DOI] [PubMed] [Google Scholar]
  41. Pircher H., Moskophidis D., Rohrer U., Bürki K., Hengartner H., Zinkernagel R. M. Viral escape by selection of cytotoxic T cell-resistant virus variants in vivo. Nature. 1990 Aug 16;346(6285):629–633. doi: 10.1038/346629a0. [DOI] [PubMed] [Google Scholar]
  42. Pircher H., Rohrer U. H., Moskophidis D., Zinkernagel R. M., Hengartner H. Lower receptor avidity required for thymic clonal deletion than for effector T-cell function. Nature. 1991 Jun 6;351(6326):482–485. doi: 10.1038/351482a0. [DOI] [PubMed] [Google Scholar]
  43. Racioppi L., Ronchese F., Matis L. A., Germain R. N. Peptide-major histocompatibility complex class II complexes with mixed agonist/antagonist properties provide evidence for ligand-related differences in T cell receptor-dependent intracellular signaling. J Exp Med. 1993 Apr 1;177(4):1047–1060. doi: 10.1084/jem.177.4.1047. [DOI] [PMC free article] [PubMed] [Google Scholar]
  44. Rammensee H. G., Falk K., Rötzschke O. Peptides naturally presented by MHC class I molecules. Annu Rev Immunol. 1993;11:213–244. doi: 10.1146/annurev.iy.11.040193.001241. [DOI] [PubMed] [Google Scholar]
  45. Ramsdell F., Lantz T., Fowlkes B. J. A nondeletional mechanism of thymic self tolerance. Science. 1989 Nov 24;246(4933):1038–1041. doi: 10.1126/science.2511629. [DOI] [PubMed] [Google Scholar]
  46. Rocha B., von Boehmer H. Peripheral selection of the T cell repertoire. Science. 1991 Mar 8;251(4998):1225–1228. doi: 10.1126/science.1900951. [DOI] [PubMed] [Google Scholar]
  47. Salaün J., Bandeira A., Khazaal I., Calman F., Coltey M., Coutinho A., Le Douarin N. M. Thymic epithelium tolerizes for histocompatibility antigens. Science. 1990 Mar 23;247(4949 Pt 1):1471–1474. doi: 10.1126/science.247.4949.1471. [DOI] [PubMed] [Google Scholar]
  48. Schumacher T. N., Ploegh H. L. Are MHC-bound peptides a nuisance for positive selection? Immunity. 1994 Dec;1(9):721–723. doi: 10.1016/s1074-7613(94)80013-8. [DOI] [PubMed] [Google Scholar]
  49. Schönrich G., Momburg F., Malissen M., Schmitt-Verhulst A. M., Malissen B., Hämmerling G. J., Arnold B. Distinct mechanisms of extrathymic T cell tolerance due to differential expression of self antigen. Int Immunol. 1992 May;4(5):581–590. doi: 10.1093/intimm/4.5.581. [DOI] [PubMed] [Google Scholar]
  50. Sebzda E., Wallace V. A., Mayer J., Yeung R. S., Mak T. W., Ohashi P. S. Positive and negative thymocyte selection induced by different concentrations of a single peptide. Science. 1994 Mar 18;263(5153):1615–1618. doi: 10.1126/science.8128249. [DOI] [PubMed] [Google Scholar]
  51. Sha W. C., Nelson C. A., Newberry R. D., Kranz D. M., Russell J. H., Loh D. Y. Positive and negative selection of an antigen receptor on T cells in transgenic mice. Nature. 1988 Nov 3;336(6194):73–76. doi: 10.1038/336073a0. [DOI] [PubMed] [Google Scholar]
  52. Sloan-Lancaster J., Evavold B. D., Allen P. M. Induction of T-cell anergy by altered T-cell-receptor ligand on live antigen-presenting cells. Nature. 1993 May 13;363(6425):156–159. doi: 10.1038/363156a0. [DOI] [PubMed] [Google Scholar]
  53. Sloan-Lancaster J., Shaw A. S., Rothbard J. B., Allen P. M. Partial T cell signaling: altered phospho-zeta and lack of zap70 recruitment in APL-induced T cell anergy. Cell. 1994 Dec 2;79(5):913–922. doi: 10.1016/0092-8674(94)90080-9. [DOI] [PubMed] [Google Scholar]
  54. Speiser D. E., Chvatchko Y., Zinkernagel R. M., MacDonald H. R. Distinct fates of self-specific T cells developing in irradiation bone marrow chimeras: clonal deletion, clonal anergy, or in vitro responsiveness to self-Mls-1a controlled by hemopoietic cells in the thymus. J Exp Med. 1990 Nov 1;172(5):1305–1314. doi: 10.1084/jem.172.5.1305. [DOI] [PMC free article] [PubMed] [Google Scholar]
  55. Speiser D. E., Pircher H., Ohashi P. S., Kyburz D., Hengartner H., Zinkernagel R. M. Clonal deletion induced by either radioresistant thymic host cells or lymphohemopoietic donor cells at different stages of class I-restricted T cell ontogeny. J Exp Med. 1992 May 1;175(5):1277–1283. doi: 10.1084/jem.175.5.1277. [DOI] [PMC free article] [PubMed] [Google Scholar]
  56. Sprent J., Lo D., Gao E. K., Ron Y. T cell selection in the thymus. Immunol Rev. 1988 Jan;101:173–190. doi: 10.1111/j.1600-065x.1988.tb00737.x. [DOI] [PubMed] [Google Scholar]
  57. Townsend A., Ohlén C., Bastin J., Ljunggren H. G., Foster L., Kärre K. Association of class I major histocompatibility heavy and light chains induced by viral peptides. Nature. 1989 Aug 10;340(6233):443–448. doi: 10.1038/340443a0. [DOI] [PubMed] [Google Scholar]
  58. Vasquez N. J., Kaye J., Hedrick S. M. In vivo and in vitro clonal deletion of double-positive thymocytes. J Exp Med. 1992 May 1;175(5):1307–1316. doi: 10.1084/jem.175.5.1307. [DOI] [PMC free article] [PubMed] [Google Scholar]
  59. Webb S. R., Sprent J. Tolerogenicity of thymic epithelium. Eur J Immunol. 1990 Nov;20(11):2525–2528. doi: 10.1002/eji.1830201127. [DOI] [PubMed] [Google Scholar]
  60. Yagi J., Janeway C. A., Jr Ligand thresholds at different stages of T cell development. Int Immunol. 1990;2(1):83–89. doi: 10.1093/intimm/2.1.83. [DOI] [PubMed] [Google Scholar]
  61. Young A. C., Zhang W., Sacchettini J. C., Nathenson S. G. The three-dimensional structure of H-2Db at 2.4 A resolution: implications for antigen-determinant selection. Cell. 1994 Jan 14;76(1):39–50. doi: 10.1016/0092-8674(94)90171-6. [DOI] [PubMed] [Google Scholar]
  62. von Boehmer H. Positive selection of lymphocytes. Cell. 1994 Jan 28;76(2):219–228. doi: 10.1016/0092-8674(94)90330-1. [DOI] [PubMed] [Google Scholar]
  63. von Herrath M. G., Dockter J., Nerenberg M., Gairin J. E., Oldstone M. B. Thymic selection and adaptability of cytotoxic T lymphocyte responses in transgenic mice expressing a viral protein in the thymus. J Exp Med. 1994 Nov 1;180(5):1901–1910. doi: 10.1084/jem.180.5.1901. [DOI] [PMC free article] [PubMed] [Google Scholar]